INVO Fertility (IVF) Operating Leases (2019 - 2025)

INVO Fertility (IVF) has 7 years of Operating Leases data on file, last reported at $2.0 million in Q3 2025.

• Quarterly Operating Leases fell 11.8% year-over-year to $2.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.0 million (down 11.8% YoY) and the FY2024 annual result came in at $2.2 million, down 34.76% from the prior year.
• Operating Leases slipped to $2.0 million in Q3 2025 per IVF's latest filing, from $2.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $3.4 million in Q3 2023 and bottomed at -$305866.0 in Q1 2023.
• The 5-year median for Operating Leases is $2.0 million (2025), against an average of $1.7 million.
• The widest annual swing landed in 2022, when Operating Leases jumped 2683.59%; it then plunged 120.82% in 2023.
• Tracing IVF's Operating Leases over 5 years: stood at $1.5 million in 2021, then fell by 10.62% to $1.3 million in 2022, then soared by 149.08% to $3.4 million in 2023, then slumped by 34.76% to $2.2 million in 2024, then slipped by 9.25% to $2.0 million in 2025.
• Per Business Quant, the three latest IVF Operating Leases figures stand at $2.0 million (Q3 2025), $2.1 million (Q2 2025), and $2.1 million (Q1 2025).

Peer Comparison